Veteran investor and corporate executive with deep experience in private equity, growth-stage investing, and corporate governance. Elizabeth Fleming is known for sourcing technology and healthcare deals, serving on boards, and driving operational improvements at portfolio companies. Background includes an MBA and prior operating roles in finance; investment style emphasizes EBITDA expansion, strategic M&A, and governance-driven value creation.
Veteran investor and corporate executive with deep experience in private equity, growth-stage investing, and corporate governance. Elizabeth Fleming is known for sourcing technology and healthcare deals, serving on boards, and driving operational improvements at portfolio companies. Background includes an MBA and prior operating roles in finance; investment style emphasizes EBITDA expansion, strategic M&A, and governance-driven value creation.
Combines a private equity mindset with growth-stage agility, prioritizing investments in technology and healthcare where operational levers and governance can drive EBITDA expansion. Prefers control or meaningful board positions to implement strategic M&A, cost structure improvement, and performance KPIs. Capital allocation favors buyouts and growth rounds with a 3–7 year horizon, disciplined downside protection, active portfolio management, and a bias toward companies where finance-led operating initiatives unlock scalable margins.
Combines a private equity mindset with growth-stage agility, prioritizing investments in technology and healthcare where operational levers and governance can drive EBITDA expansion. Prefers control or meaningful board positions to implement strategic M&A, cost structure improvement, and performance KPIs. Capital allocation favors buyouts and growth rounds with a 3–7 year horizon, disciplined downside protection, active portfolio management, and a bias toward companies where finance-led operating initiatives unlock scalable margins.
| Trades 809 | Longs Won 501/809 61% | Profit Factor 6.83 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $824,423.78 |
| Average Win $191,406.67 | Best Trade (Mar 30) $18M | Sharpe Ratio -11.55 |
| Average Loss -$45,571.13 | Worst Trade (Jul 16) -$6.02M | Z-Score -0.97 (66.73%) |
| Commissions $0 | Avg. Trade Length 11m 1w 4d | Expectancy $101,185.21 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.03% |
| Consecutive Losing Trades | 5,618 | 5,056 | 4,494 | 3,933 | 3,371 | 2,809 | 2,247 | 1,685 | 1,124 | 562 |